Euromonitor International’s Senior Research Analyst Alex Esposito interviews Cindy Bryant, Chief Business Officer at Demetrix about the world of cannabinoids beyond THC and CBD. Cindy explains Demetrix’s unique approach to using fermentation to produce cannabinoids and how this differs from predominant production methods. Alex and Cindy also delve into the potential of new cannabinoids other than THC and CBD, ways they can help consumers and how we’re only just beginning to understand the promise of cannabinoids for use in health and wellness. Learn more about Demetrix at their website, and dive into their unique approach to producing cannabinoids their blog.
Nicotine and Cannabis
Explore thought-leadership and expert insights on the consumer behaviour, regulatory forces and cutting-edge innovation trends shaping the complex and rapidly developing nicotine and cannabis industries.
Find content by
Cannabinoids Beyond THC and CBD: An Interview with Cindy Bryant, Chief Business Officer at Demetrix
2/24/2021Explore More
Shop Our Reports
Building Market Resilience: Applying Crisis Learnings to the Iran War
The 2026 Iran conflict marks the fourth major economic disruption to global consumer markets in under two decades. While each crisis originated differently,…
View ReportTop Five Trends in Cannabis
Regulatory volatility, corporate challenges, the rise of telemedicine and the boom in the HDIC space in the US are leading to both challenges and opportunities…
View ReportEmerging Substances and the Rise of Transgressive Wellness
Spurred by macro uncertainty and the cross-pollination of clinical, illicit and wellbeing trends, transgressive wellness is prompting consumers to re-examine…
View Report